Halogenated dodecaborates, and especially dodecaiodododecaborate(2-), are found to trigger effectively the release of the contents of phospholipid liposomes, including liposomes containing distearoylphosphatidylcholine and cholesterol, which are used clinically in cancer therapy. The basis of the release is studied through differential scanning calorimetry, cryo-transmission electron microscopy, and atomic force microscopy. Upon administration at high concentrations, drastic morphological changes are induced by the dodecaborates. Their possible use in triggered release is suggested.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/cplu.201402286 | DOI Listing |
Publication Analysis
Top Keywords
halogenated dodecaborate
4
dodecaborate clusters
4
clusters agents
4
agents trigger
4
release
4
trigger release
4
release liposomal
4
liposomal contents
4
contents halogenated
4
halogenated dodecaborates
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!